{
    "2019-05-14": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Ionis Pharmaceuticals Is 40% of the Way There",
                "features": {
                    "keywords": [
                        "Ionis",
                        "Pharmaceuticals",
                        "40%",
                        "progress"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "Regeneron (REGN) Gets FDA Nod for Eylea Label Expansion",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "FDA",
                        "Eylea",
                        "label expansion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "Generic Drugmakers Face Antitrust Suit Alleging Price Fixing",
                "features": {
                    "keywords": [
                        "Generic",
                        "Drugmakers",
                        "Antitrust",
                        "Price Fixing"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}